Teleflex
Clinical trials sponsored by Teleflex, explained in plain language.
Medical device company making catheters, surgical instruments, and respiratory products.
Trade on eToro (ad)Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
-
New stent aims to clear long heart blockages safely
Disease control Recruiting nowThis study tests a new stent (Orsiro Mission) that slowly releases a drug to keep heart arteries open. It is for people with long blockages (over 36 mm) in their heart arteries. About 150 participants will be followed for up to 5 years to see if the stent is safe and effective at…
Phase: NA • Sponsor: Teleflex • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Dissolvable magnesium stent could revolutionize heart disease treatment
Disease control Recruiting nowThis study tests a new device called Freesolve, a temporary magnesium scaffold that props open blocked heart arteries and then dissolves over time. About 1,859 people with up to two new blockages will receive either this scaffold or a standard permanent stent. The goal is to see …
Phase: NA • Sponsor: Teleflex • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Can a massive Real-World registry make vascular access safer?
Knowledge-focused Recruiting nowThis study is a large registry that will follow about 2,500 people who receive a Teleflex vascular access device—such as a central venous catheter, dialysis catheter, or peripheral IV—during their medical care. The goal is to collect real-world data on how well these devices work…
Sponsor: Teleflex • Aim: Knowledge-focused
Last updated Aug 13, 2026 00:00 UTC